Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Norway

Innovation Action · Running

AIMARIA Accelerating Innovation in Marine AI-powered Bioprospecting

Coordinator
Norges Teknisk-Naturvitenskapelige Universitet NTNU, Norway
Runs
1 September 2026 to 31 August 2030
Status
Running
EU funding
€6.0m
Total cost
€6.3m
Partners
12 organisations in 9 countries
Type
Innovation Action
Grant agreement
101291450

What the project is doing

In the project's own words, from its summary on CORDIS.

AIMARIA delivers a digital-to-pilot pipeline to unlock the vast but underexploited biosynthetic capacity of marine microbiomes. The project combines AI-driven prioritisation, digital twins, and AI-powered predictive DNA design with advanced synthetic biology, cell-free systems, and engineered novel and established microbial chassis. Through this integrated approach, AIMARIA will deliver sustainable and scalable access to high-value marine natural products, including stalled oncology candidates, such as Peloruside A and Pateamine A, and discover first-in-class bioactive compounds and enzymes.

By demonstrating TRL 6–7 production routes, embedding life cycle and techno-economic assessments, and ensuring compliance with international biodiversity frameworks (Nagoya, KM-GBF, BBNJ), AIMARIA directly supports the EU Bioeconomy Strategy and its objectives to develop sustainable, circular bio-based solutions. The project will strengthen Europe’s leadership in blue biotechnology, accelerate innovation across multiple industrial sectors, and support the objectives of the EU Green Deal and Mission “Restore our Ocean and Waters"".""

Topics

Who is involved

OrganisationCityCountryRole
Norges Teknisk-Naturvitenskapelige Universitet NTNUTrondheimNorwayCoordinator
Vib VzwZwijnaarde - GentBelgiumParticipant
Eidgenoessische Technische Hochschule ZuerichZuerichSwitzerlandParticipant
Helmholtz-Zentrum Fur Infektionsforschung GmbHBraunschweigGermanyParticipant
Leibniz-Institut Dsmz-Deutsche Sammlung Von Mikroorganismen Und Zellkulturen GmbHBraunschweigGermanyParticipant
Algorithmiq OyHelsinkiFinlandParticipant
Wageningen UniversityWageningenNetherlandsParticipant
Syngens ASHeimdalNorwayParticipant
The Research Trust of Victoria University of WellingtonWellingtonNew ZealandParticipant
Astrazeneca ABSodertaeljeSwedenAssociatedpartner
Imperial College of Science Technology and MedicineLondonUnited KingdomParticipant
Prozomix LimitedHaltwhistleUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI